IRON (Disc Medicine) Insider Ownership: 2.58 % (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IRON Disc Medicine Inc IRON
34 GF Score
Price $82.61
! 3 Warning Signs
View Full Analysis

What is Disc Medicine Insider Ownership?

Disc Medicine IRON -0.17% 34 Insider Ownership is 2.58 % as of Aug. 27, 2026. GuruFocus rates IRON with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Disc Medicine's insider ownership is 2.58%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Disc Medicine's Institutional Ownership is 109.37%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Disc Medicine's Float Percentage Of Total Shares Outstanding is 85.76%.

Disc Medicine Insider Ownership Historical Data

* Premium members only.

The historical data trend for Disc Medicine's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Disc Medicine Insider Ownership Chart

Disc Medicine Historical Data

The historical data trend for Disc Medicine can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 2.59 2.58 2.61 2.42 2.40 2.41 2.68 2.60 2.60 2.58
IRON
34GF Score
Disc Medicine Inc IRON
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Disc Medicine Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 2.58 % mean?
Disc Medicine (IRON) has a Insider Ownership of 2.58 % as of Aug. 27, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Disc Medicine and its competitors.
Is Disc Medicine's Insider Ownership too high?
Disc Medicine's current Insider Ownership is 2.58 %. Overall, Disc Medicine has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Disc Medicine's Insider Ownership compare to CLDX and MBX?
Disc Medicine's Insider Ownership of 2.58 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Disc Medicine and its competitors. Disc Medicine's current Insider Ownership is 2.58 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Disc Medicine stock overvalued right now?
Disc Medicine (IRON) has a current Insider Ownership of 2.58 %. The current Insider Ownership is 2.58 %. Disc Medicine's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Disc Medicine (IRON), the current Insider Ownership is 2.58 % as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Disc Medicine Business Description

Address 321 Arsenal Street, Suite 101, Watertown, MA, USA, 02472
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
34GF Score

Get the complete analysis for IRON

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.61
Price